Survival Comparison of Midgut and Pancreatic Neuroendocrine Tumours
Author Information
Author(s): Johanson V, Tisell L E, Olbe L, Wängberg B, Nilsson O, Ahlman H
Primary Institution: Sahlgrenska University Hospital, Göteborg University
Hypothesis
The study aims to compare the survival rates of patients with midgut carcinoid tumours and those with malignant endocrine pancreatic tumours.
Conclusion
Patients with pancreatic neuroendocrine tumours have a worse prognosis compared to those with midgut carcinoid tumours.
Supporting Evidence
- The study included 64 patients with midgut carcinoid tumours and 25 patients with pancreatic tumours.
- Hepatic metastases were found to indicate a worse prognosis in pancreatic neuroendocrine tumours.
Takeaway
This study looked at how long people with two types of cancer lived and found that one type is generally more serious than the other.
Methodology
A retrospective study comparing survival of 64 patients with midgut carcinoid tumours and 25 patients with pancreatic tumours.
Participant Demographics
64 patients with midgut carcinoid tumours and 25 patients with pancreatic tumours.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website